Salesforce Inc (CRM) Stock Price Today
Aura AI Summary
Key Stats
- $188.61BMarket Cap
- 7,886,465Volume
- TechnologySector
- $266.2352W High
- $150.1252W Low
- 89 DaysTypical Hold Time
- $218.95BEnterprise Value
- 0.77%Div Yield
- -Trading Activity
Track Salesforce Inc (CRM) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Salesforce Inc has traded between a low of $150.12 and a high of $266.23, highlighting its annual price range. Buy and sell Salesforce Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Salesforce Inc
Salesforce Inc provides enterprise cloud computing solutions. The company offers customer relationship management technology that brings companies and customers together. Its Customer 360 platform helps the group to deliver a single source of truth, connecting customer data across systems, apps, and devices to help companies sell, service, market, and conduct commerce. It also offers Service Cloud for customer support, Marketing Cloud for digital marketing campaigns, Commerce Cloud as an e-commerce engine, the Salesforce Platform, which allows enterprises to build applications, and other solutions, such as MuleSoft for data integration.
Most Recent News
Survey finds US consumers use AI agents but distrust them with financial info, blaming companies for fraud.
A SEON survey of 2,026 U.S. adults reveals that while 68% use AI agents weekly for personal tasks, half are uncomfortable letting AI handle credit card purchases. Only 15% would share financial info with AI, and 43% lack confidence in spotting fraudu...

Radiopharm Theranostics advances multiple cancer drug trials, prepares Phase 3 study for brain metastases imaging.
Radiopharm Theranostics announced progress in its oncology radiopharmaceutical pipeline, including preparing for a pivotal Phase 3 imaging trial of RAD101 for recurrent brain metastases after a successful FDA End-of-Phase 2 meeting. The company also ...

Alvotech to present at four major investor conferences in November across Europe.
Alvotech, a global biotechnology company specializing in biosimilar medicines, will participate in four international investor conferences in November held in the UK, Norway, and Sweden. These events include presentations and analyst discussions host...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.